Found: 2
Select item for more details and to access through your institution.
A phase I/II trial of vorinostat (SAHA) in combination with rituximab‐CHOP in patients with newly diagnosed advanced stage diffuse large B‐cell lymphoma (DLBCL): SWOG S0806.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 4, p. 486, doi. 10.1002/ajh.25010
- By:
- Publication type:
- Article
Patient-reported tolerability of adjuvant ipilimumab (3 or 10 mg/kg) versus high-dose interferon alfa-2b for resected high-risk stage III–IV melanoma in phase III trial E1609.
- Published in:
- Quality of Life Research, 2023, v. 32, n. 1, p. 183, doi. 10.1007/s11136-022-03226-8
- By:
- Publication type:
- Article